Summary: LivaNova announced positive results from its OSPREY clinical trial, showing that its investigational aura6000 hypoglossal nerve stimulator significantly reduces the severity of obstructive sleep apnea (OSA) after six months of therapy. The study met its primary safety … [Read more...]
Genio Neurostimulator Reduces AHI in Supine and Non-Supine Positions
Summary: Nyxoah SA presented additional data from its DREAM US study on the Genio neurostimulation system for treating obstructive sleep apnea (OSA) at the 2024 International Surgical Sleep Society (ISSS) Educational Update, which showed that Genio’s bilateral stimulation … [Read more...]